Flurbiprofen, S(+), eyedrops: Formulation, enantiomeric assay, shelflife and pharmacology

Pharmacy World and Science

Volumn 21, Issue 2, 1999, Pages 91-95

  Van Sorge, Adriaan A ^a   Wijnen, Peter H ^b   Van Delft, Jan L ^c   Carballosa Coré Bodelier, Valérie M W ^d   Van Haeringen, Nicolaas J ^d  

^a RIJNSTATE HOSPITAL   (Netherlands)

^b AKZO NOBEL CENTRAL RESEARCH   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

COX 1; Enantiomer; Eyedrops; Flurbiprofen; Indomethacin; Prostaglandins

Indexed keywords

CYCLOOXYGENASE 1; EYE DROPS; FLURBIPROFEN; INDOMETACIN; PROSTAGLANDIN;

ANIMAL TISSUE; APHAKIA; ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CATARACT EXTRACTION; CATTLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFECT; DRUG FORMULATION; ENANTIOMER; NONHUMAN; POSTOPERATIVE COMPLICATION; PROSTAGLANDIN SYNTHESIS INHIBITION; SHELF LIFE; STEREOCHEMISTRY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; ELECTROPHORESIS, CAPILLARY; FLURBIPROFEN; OPHTHALMIC SOLUTIONS; PROSTAGLANDINS; STEREOISOMERISM;

EID: 0032977263     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008609513880     Document Type: Article

References (29)

1. Waitzman, MB. Possible new concepts relating prostaglandins to various ocular functions Survey of Ophthalmology 1970;14:301-26
2. Eakins KE Whitelocke RAF, Perkins ES, Bennett A, and Unger WG. Release of a prostaglandin in ocular inflammation Nature 1972;239:248-9
3. Worst JGF. Biotoxizität des Kammerwassers. Eine vereinheitlichende pathologische Theorie, begründet auf hypothetische biotoxische Kammerwasserfaktoren. Klin Mbl Augenheilk 1975;167:376-84.
4. Lute NP, Vyth A, De Keizer RJW. Indometacine oogdruppels 0,5%. Pharm Weekbl 1980;115:1663-4
5. Van Nispen tot Pannerden EBLM, Van Sorge AA. Waterige oogdruppels met indometacine in oplossing. Pharm Weekbl 1981;116:386-7
6. Cox HLM van der Graaf H. Indometacine-oogdruppels als oplossing. Pharm Weekbl 1981;116:387-8
7. Van Sorge AA, Van Nispen tot Pannerden EBLM, Janssen HWM. Oogdruppels met lage concentratie indometacine: bereidingsvoorschrift en onderzoek naar de werkzaamheid. Pharm Weekbl 1986;121:1039-46.
8. Van Haeringen NJ, Oosterhuis JA, van Delft JL, Glasius E and Noach EL. A comparison of the effects of non-steroidal compounds on the disruption of the blood-aqueous barrier. Exp Eye Res 1982;35:271-7.
9. Vane JR. Inhibition of prostaglandinsynthesis as a mechanism of action for aspirin-like drugs. Nature 1971;231:232-5
10. Takeguchi C and Sih CJ. A rapid spectrophotometric assay for prostaglandin synthetase: application to the study of non-steroidal anti-inflammatory agents. Prostaglandins 1972;2:169-84
11. Tilden ME, Boney RS, Goldenberg MM and Rosenbaum JT. The effects of topical S[+]-ibuprofen on interleukin-1 induced ocular inflammation in a rabbit model. J Ocul Pharmacol 1990;6:131-5
12. Tjebbes GWA, van Delft JL, Barthen ER, van Haeringen NJ. d-Flurbiprofen in ocular inflammation induced by paracentesis of the rabbit eye. Prostaglandins 1990;40:29-33
13. Stampinato S, Marino A, Bucolo C, Canossa M, Bachetti T, Mangiafico S. Effects of sodium naproxen eye drops on rabbit ocular inflammation induced by sodium arachidonate. J Ocul. Pharmacol. 1991,7:125-33
14. Van Sorge AA, van Delft JL, Bodelier VMW, Wijnen PH, van Haeringen NJ. Specificity of flurbiprofen and enantiomers for inhibition of prostaglandin synthesis in bovine iris/cilliary body. Prostaglandins 1998;55:169-77.
15. Kean WF, Lock CJL, Howard-Lock HE. Chirality in antirheumatic drugs. Lancet 1991;338:1565-68
16. Van Sorge AA, Essink AWG, van Delft JL and van Haeringen NJ. Pharmacokinetics of flurbiprofen enantiomers in two rabbit species. Ophthalmic Research 1997;29:S1: 033
17. Altria KD, Walsh AR and Smith NW. Validation of a capillary electrophoresis method for the enantiomeric purity testing of fluparoxan. J Chromatogr. 1993;645:193-6
18. Nielen MWF. Chiral separation of basic drugs using cyclodextrin-modified capillary zone electrophoresis. Anal. Chem. 1993;65:885-93,
19. Guttman A and Cooke N. Practical aspects in chiral separation of pharmaceuticals by capillary electrophoresis. II Quantitative separation of naproxen enantiomers. J Chromatogr A 1994;685:155-9
20. Altria KD, Goodall DM and Rogan MM. Quantitative applications and validation of the resolution of enantiomers by capillary electrophoresis. Electrophoresis, 1994;15:824-7
21. Gasper MP, Bethod A, Nair UB and Armstrong DW. Comparison and modeling study of vancomycin, ristocetin A, and teicoplanin for CE enantioseperations. Anal Chem 1996;68: 2501-14
22. Ward TJ, Dann III C, Brown AP. Separation of enantiomers using vancomycin in a countercurrent process by suppression of electroosmosis. Chirality 1996;8:77-83
23. Vespalec R, Billiet HAH, Frank J, Bocek P Vancomycin as a chiral selector in capillary electrophoresis: an appraisal of advantages and limitations. Electrophoresis 1996;17:1214-21
24. Rauws AG, Groen K. Current regulatory [draft] guidance on chiral medicinal products: canada, eec, japan, united states. Chirality 1994;6:72-5
25. Menzel-Soglowek S, Geisslinger G, Beck WS, Brune K Variability of inversion of R(-)-flurbiprofen in different species J Pharm Sci 1992;81:888-91
26. Geisslinger G, Menzel-Soglowek S, Schuster O, Brune K. Stereoselective high performance liquid chromatographic determination of flurbiprofen in plasma. J Chrom 1992;573:163-7
27. Anderson JA, Chen CC, Vita JB, Shackleton M. Disposition of topical flurbiprofen in normal and aphakic rabbit eyes. Arch Ophthalmol 1982;100:642-5
28. Tang-Liu DD-S, Liu SS, Weinkam RJ. Ocular and systemic bioavailability of ophthalmic flurbiprofen. J Pharmcokin Biopharm 1984;12:611-26
29. Ellis PP, Pfoff DS, Bloedow DC, Riegel M. Intraocular diclofenac and flurbiprofen concentrations in human aqueous humor following topical application. J Ocular Pharmacol 1994;10:677-82